Effects of hyperoxia on myocardial injury following cardioversion—A randomized clinical trial
- 1 February 2018
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 196, 97-104
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated CopeptinCirculation: Heart Failure, 2011
- Relationship Between Supranormal Oxygen Tension and Outcome After Resuscitation From Cardiac ArrestCirculation, 2011
- Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation TrialJournal of Internal Medicine, 2010
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial InfarctionCirculation, 2007
- Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston MarathonCirculation, 2006
- Normoxic Resuscitation after Cardiac Arrest Protects against Hippocampal Oxidative Stress, Metabolic Dysfunction, and Neuronal DeathJournal of Cerebral Blood Flow & Metabolism, 2006
- Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillationThe American Journal of Cardiology, 2004
- Serum troponins T and I after elective cardioversionEuropean Heart Journal, 2000
- Controlled trial of oxygen in uncomplicated myocardial infarction.BMJ, 1976